These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27469343)

  • 1. Bullous Pemphigoid with Lymphocytic Colitis: A Case Report and Short Literature Review.
    Sperl A; Bauer JW; Meyersburg D
    Dermatol Ther (Heidelb); 2016 Sep; 6(3):437-41. PubMed ID: 27469343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of IgA antibodies in pemphigus, bullous pemphigoid and mucous membrane pemphigoid.
    Cozzani E; Drosera M; Parodi A; Carrozzo M; Gandolfo S; Rebora A
    Acta Derm Venereol; 2004; 84(5):381-4. PubMed ID: 15370705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the subepidermal autoimmune blistering diseases linear IgA disease and the pemphigoid group and inflammatory bowel disease: two case reports and literature review.
    Shipman AR; Reddy H; Wojnarowska F
    Clin Exp Dermatol; 2012 Jul; 37(5):461-8. PubMed ID: 22712854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual diagnosis of Pemphigus and pemphigoid. Retrospective review of thirty cases in the literature.
    Sami N; Ahmed AR
    Dermatology; 2001; 202(4):293-301. PubMed ID: 11455140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid.
    Alpsoy E; Akman-Karakas A; Uzun S
    Arch Dermatol Res; 2015 May; 307(4):291-8. PubMed ID: 25589418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany.
    Bertram F; Bröcker EB; Zillikens D; Schmidt E
    J Dtsch Dermatol Ges; 2009 May; 7(5):434-40. PubMed ID: 19170813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune blistering dermatoses as systemic diseases.
    Vassileva S; Drenovska K; Manuelyan K
    Clin Dermatol; 2014; 32(3):364-75. PubMed ID: 24767184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgA bullous pemphigoid: a distinct blistering disorder. Case report and review of the literature.
    Jones RR; Goolamali SK
    Br J Dermatol; 1980 Jun; 102(6):719-25. PubMed ID: 7000138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-paraneoplastic autoimmune subepidermal bullous disease associated with fatal bronchiolitis obliterans.
    Orime M; Tomiyama K; Hashidate H; Yoshida S; Hokari S; Tsuda A; Yokoyama H; Narita JI; Uchida Y; Kanekura T; Abe R; Ishii N; Hashimoto T; Kawai K
    J Dermatol; 2017 Apr; 44(4):461-464. PubMed ID: 27914107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of internal malignancies in pemphigus and bullous pemphigoid in Japan.
    Ogawa H; Sakuma M; Morioka S; Kitamura K; Sasai Y; Imamura S; Inaba Y
    J Dermatol Sci; 1995 Mar; 9(2):136-41. PubMed ID: 7772576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap.
    Wojnarowska F; Marsden RA; Bhogal B; Black MM
    J Am Acad Dermatol; 1988 Nov; 19(5 Pt 1):792-805. PubMed ID: 3056993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management.
    Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):26-51. PubMed ID: 28779299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bullous pemphigoid and ulcerative colitis.
    Ahmed AR; Kaplan RP; Hardy D; Feldman E; Pitt H
    Int J Dermatol; 1982 Dec; 21(10):594-8. PubMed ID: 6761284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid.
    Dainichi T; Chow Z; Kabashima K
    J Dermatol Sci; 2017 Dec; 88(3):265-270. PubMed ID: 28747266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Autoimmune Bullous Diseases in Elderly Patients in Iran: A 10-Year Retrospective Study.
    Ghiasi M; Daneshpazhooh M; Ismonov M; Chams-Davatchi C
    Skinmed; 2017; 15(3):175-180. PubMed ID: 28705276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipeptidyl-Peptidase 4 Inhibitor-Induced Variants of Bullous Pemphigoid: A Case Series of Four Patients.
    Balighi K; Heidari S; Kavyani M; Kamyab Hesari K; Tootoonchi N
    Case Rep Dermatol; 2022; 14(3):350-355. PubMed ID: 36466751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New and emerging therapies in the treatment of blistering diseases.
    Korman NJ
    Dermatol Clin; 2000 Jan; 18(1):127-37, ix-x. PubMed ID: 10626118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistence of pemphigus foliaceus and bullous pemphigoid. Demonstration of autoantibodies that bind to both the pemphigus foliaceus antigen complex and the bullous pemphigoid antigen.
    Korman NJ; Stanley JR; Woodley DT
    Arch Dermatol; 1991 Mar; 127(3):387-90. PubMed ID: 1998370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases.
    Lamberts A; Euverman HI; Terra JB; Jonkman MF; Horváth B
    Front Immunol; 2018; 9():248. PubMed ID: 29520266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucous Membrane Pemphigoid, Bullous Pemphigoid, and Anti-programmed Death-1/ Programmed Death-Ligand 1: A Case Report of an Elderly Woman With Mucous Membrane Pemphigoid Developing After Pembrolizumab Therapy for Metastatic Melanoma and Review of the Literature.
    Zumelzu C; Alexandre M; Le Roux C; Weber P; Guyot A; Levy A; Aucouturier F; Mignot-Grootenboer S; Caux F; Maubec E; Prost-Squarcioni C
    Front Med (Lausanne); 2018; 5():268. PubMed ID: 30320114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.